What causes low hematocrit
Pro Research Analysisby 
Searched over 200M research papers
Causes of Low Hematocrit
Anemia and Erythropoietin Deficiency
One of the primary causes of low hematocrit is anemia, which can result from a deficiency in erythropoietin. Erythropoietin is a hormone produced by the kidneys that stimulates the production of red blood cells (RBCs). In patients with end-stage renal disease, the kidneys fail to produce adequate amounts of erythropoietin, leading to anemia and consequently low hematocrit levels . This condition is often managed with recombinant human erythropoietin (epoetin) to partially correct the anemia.
Impact on Bleeding Time
Low hematocrit is also implicated in the pathogenesis of prolonged bleeding time in anemic patients. The relationship between hematocrit and bleeding time is well-documented, with evidence suggesting that transfusion of RBCs can correct the prolonged bleeding time often observed in these patients . Two hypotheses explain this phenomenon:
- Platelet Dispersion: In small blood vessels, RBCs help disperse platelets towards the subendothelial surface, promoting interaction with the blood vessel wall.
- Platelet Activation: Following injury to a small blood vessel, RBCs release small amounts of adenosine diphosphate (ADP) into the microvasculature, activating platelets through hemolysis during hemostasis .
Clinical Implications
The clinical implications of low hematocrit are significant, particularly in the treatment of anemic patients with a bleeding tendency. Understanding the role of hematocrit in bleeding time can guide therapeutic strategies, such as RBC transfusions, to manage bleeding risks effectively .
Hemodialysis and Cardiac Disease
In patients with cardiac disease undergoing hemodialysis, maintaining a low hematocrit is often a clinical decision. A study comparing normal and low hematocrit values in such patients found that raising the hematocrit to 42 percent did not significantly improve survival rates and was associated with a decline in the adequacy of dialysis and increased need for intravenous iron dextran . Therefore, maintaining a lower hematocrit may be more beneficial in these patients to avoid additional complications.
Conclusion
Low hematocrit can result from anemia due to erythropoietin deficiency, particularly in patients with renal disease. It is also associated with prolonged bleeding time, which can be managed through RBC transfusions. In patients with cardiac disease undergoing hemodialysis, maintaining a lower hematocrit may be preferable to avoid further complications. Understanding these causes and implications is crucial for effective clinical management of patients with low hematocrit.
Sources and full results
Most relevant research papers on this topic